Liver-specific inhibition of Lin28B for treatment of hepatocarcinoma
People
(Co-responsible)
External participants
Hall Jonathan
(Third-party responsible)
Additional information
Start date
01.07.2022
End date
30.06.2025
Duration
36 Months
Funding sources
Lega contro il Cancro
Status
Active
Category
Competitive Foundations /
Lega contro il Cancro